Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Anhydrous Sodium Citrate
2. Citra Ph
3. Monosodium Citrate
4. Sodium Citrate
5. Sodium Citrate Dihydrate
6. Sodium Citrate Monobasic
7. Sodium Citrate, Anhydrous
1. Sodium Citrate Dihydrate
2. 6132-04-3
3. Sodium Citrate Tribasic Dihydrate
4. Sodium Citrate Hydrate
5. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Trisodium Salt, Dihydrate
6. Citric Acid Trisodium Salt Dihydrate
7. Trisodium;2-hydroxypropane-1,2,3-tricarboxylate;dihydrate
8. Mfcd00150031
9. Trisodium 2-hydroxypropane-1,2,3-tricarboxylate Dihydrate
10. Sodium Citrate, Dihydrate
11. B22547b95k
12. Citric Acid, Trisodium Salt, Dihydrate
13. Sodium Citrate Hydrous
14. Trisodium Citrate Dihydrate;citric Acid Trisodium Salt Dihydrate
15. Mfcd00130806
16. Tri-sodium Citrate Dihydrate
17. Sodium 2-hydroxypropane-1,2,3-tricarboxylate Dihydrate
18. Sodiumcitrate
19. N-1560
20. Natrum Citricum
21. Tricitrasol (tn)
22. Sodium Citrate (tn)
23. Sodium Citrate [usp:jan]
24. Sodiumcitratetribasicdihydrate
25. Sodium Citrate [fhfi]
26. Dtxsid1049437
27. Sodium Citrate Hydrate (jp17)
28. Unii-b22547b95k
29. Chebi:32142
30. Trisodium Citrate Dihydrate, Acs
31. Sodium Citrate Hydrous [ii]
32. Sodium Citrate Hydrate [jan]
33. Sodium Citrate [ep Monograph]
34. Sodium Citrate Dihydrate [mi]
35. Akos025293920
36. Citronensaeure,trinatrium-salz-dihydrat
37. Sodium Citrate Dihydrate, >=99%, Fg
38. Sodium Citrate Dihydrate [vandf]
39. Trisodium Citrate Dihydrate [ii]
40. Bp-31019
41. Sodium Citrate Dihydrate [who-dd]
42. Citrate, 0.5m Buffer Solution, Ph 3.0
43. Citrate, 0.5m Buffer Solution, Ph 4.0
44. Citrate, 0.5m Buffer Solution, Ph 4.5
45. Citrate, 0.5m Buffer Solution, Ph 5.0
46. Citrate, 0.5m Buffer Solution, Ph 5.5
47. Citrate, 0.5m Buffer Solution, Ph 6.0
48. Sodium Citrate Tribasic Dihydrate, >=98%
49. Sodium Citrate Dihydrate, Acs Reagent Grade
50. Sodium Citrate, Dihydrate [who-ip]
51. D01781
52. Sodium Citrate Tribasic Dihydrate, Ar, >=99%
53. Sodium Citrate Tribasic Dihydrate, Lr, >=99%
54. Citric Acid Trisodium Salt Dihydrate Acs Reagent
55. Natrii Citras, Dehydrate [who-ip Latin]
56. A833161
57. A835986
58. Trisodium Citrate Dihydrate [usp Monograph]
59. Q22075862
60. Sodium Citrate Dihydrate Biochemical Grade, Fine Granular
61. Sodium Citrate Tribasic Dihydrate, Usp, 99.0-100.5%
62. Sodium Citrate Tribasic Dihydrate (molecular Biology Grade)
63. Sodium Citrate Tribasic Dihydrate, Acs Reagent, >=99.0%
64. Trisodium 2-oxidanylpropane-1,2,3-tricarboxylate Dihydrate
65. Citric Acid Trisodium Salt Dihydratetrisodium Citrate Dihydrate
66. Sodium Citrate Tribasic Dihydrate, Bioultra, >=99.0% (nt)
67. Sodium Citrate Tribasic Dihydrate, Insect Cell Culture Tested
68. Sodium Citrate Tribasic Dihydrate, Jis Special Grade, >=99.0%
69. Sodium Citrate Tribasic Dihydrate, P.a., Acs Reagent, 99.0%
70. Sodium Citrate Tribasic Dihydrate, Purum P.a., >=99.0% (nt)
71. Sodium Citrate Tribasic Dihydrate, Saj First Grade, >=99.0%
72. Sodium Citrate Tribasic Dihydrate, Tested According To Ph.eur.
73. Trisodium 2-hydroxypropane-1,2,3-tricarboxylate--water (1/2)
74. Trisodium Citrate Dihydrate, Meets Usp Testing Specifications
75. 2-hydroxy-1,2,3-propanetricarboxylic Acid Trisodium Salt Dihydrate
76. Sodium Citrate Tribasic Dihydrate, Bioxtra, >=99.0% (titration)
77. Sodium Citrate Tribasic Dihydrate, For Molecular Biology, >=99%
78. Sodium Citrate Tribasic Dihydrate, Vetec(tm) Reagent Grade, 98%
79. Sodium Citrate, United States Pharmacopeia (usp) Reference Standard
80. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Sodium Salt, Dihydrate
81. Sodium Citrate Tribasic Dihydrate, P.a., Acs Reagent, Reag. Iso, 99-101%
82. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Sodium Salt, Hydrate (1:3:2)
83. Sodium Citrate Tribasic Dihydrate, Bioultra, For Molecular Biology, >=99.5% (nt)
84. Sodium Citrate Tribasic Dihydrate, Puriss. P.a., Acs Reagent, >=99.0% (nt)
85. Sodium Citrate Tribasic Dihydrate, Suitable For Amino Acid Analysis, >=99.0%
86. Sodium Citrate, Pharmaceutical Secondary Standard; Certified Reference Material
87. Sodium Citrate Tribasic Dihydrate, Puriss. P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., >=99.5%
88. Sodium Citrate Tribasic Dihydrate, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, Fcc, E331, 99-100.5% (calc. To The Dried Substance)
89. Sodium Citrate Tribasic Dihydrate, Suitable For Amino Acid Analysis, >=98% (titration), Powder
Molecular Weight | 294.10 g/mol |
---|---|
Molecular Formula | C6H9Na3O9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 293.99396471 g/mol |
Monoisotopic Mass | 293.99396471 g/mol |
Topological Polar Surface Area | 143 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 6 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Buffers
A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. (See all compounds classified as Buffers.)
Food Preservatives
Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
61
PharmaCompass offers a list of Trisodium Citrate Dihydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trisodium Citrate Dihydrate manufacturer or Trisodium Citrate Dihydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trisodium Citrate Dihydrate manufacturer or Trisodium Citrate Dihydrate supplier.
PharmaCompass also assists you with knowing the Trisodium Citrate Dihydrate API Price utilized in the formulation of products. Trisodium Citrate Dihydrate API Price is not always fixed or binding as the Trisodium Citrate Dihydrate Price is obtained through a variety of data sources. The Trisodium Citrate Dihydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 71402_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 71402_FLUKA, including repackagers and relabelers. The FDA regulates 71402_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 71402_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 71402_FLUKA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 71402_FLUKA supplier is an individual or a company that provides 71402_FLUKA active pharmaceutical ingredient (API) or 71402_FLUKA finished formulations upon request. The 71402_FLUKA suppliers may include 71402_FLUKA API manufacturers, exporters, distributors and traders.
click here to find a list of 71402_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 71402_FLUKA DMF (Drug Master File) is a document detailing the whole manufacturing process of 71402_FLUKA active pharmaceutical ingredient (API) in detail. Different forms of 71402_FLUKA DMFs exist exist since differing nations have different regulations, such as 71402_FLUKA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 71402_FLUKA DMF submitted to regulatory agencies in the US is known as a USDMF. 71402_FLUKA USDMF includes data on 71402_FLUKA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 71402_FLUKA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 71402_FLUKA suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 71402_FLUKA Drug Master File in Japan (71402_FLUKA JDMF) empowers 71402_FLUKA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 71402_FLUKA JDMF during the approval evaluation for pharmaceutical products. At the time of 71402_FLUKA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 71402_FLUKA suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 71402_FLUKA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 71402_FLUKA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 71402_FLUKA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 71402_FLUKA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 71402_FLUKA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 71402_FLUKA suppliers with NDC on PharmaCompass.
71402_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 71402_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 71402_FLUKA GMP manufacturer or 71402_FLUKA GMP API supplier for your needs.
A 71402_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 71402_FLUKA's compliance with 71402_FLUKA specifications and serves as a tool for batch-level quality control.
71402_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 71402_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
71402_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (71402_FLUKA EP), 71402_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (71402_FLUKA USP).